High-Risk Pregnancy Care Denied by Insurance? How to Appeal

A high-risk pregnancy requires specialized care — yet insurance companies routinely deny, delay, or underfund the very services that protect mothers and babies in the most vulnerable pregnancies. If your insurer has denied a cervical cerclage, 17-OHPC injections, maternal-fetal medicine specialist visits, fetal monitoring, or NICU pre-authorization, here is how to build a successful appeal.

What Makes a Pregnancy High-Risk?

High-risk pregnancies — also called "complicated pregnancies" — are those where the mother, baby, or both face an elevated risk of complications. Common high-risk conditions include:

• Prior preterm birth or cervical incompetence
• Multiple gestation (twins, triplets)
• Gestational diabetes or pregestational diabetes
• Chronic hypertension or preeclampsia
• Placenta previa or placenta accreta
• Fetal growth restriction or anomaly
• Advanced maternal age (35+)
• History of pregnancy loss or miscarriage

These conditions are well-recognized in obstetric medicine. When your OB refers you to a maternal-fetal medicine (MFM) specialist or perinatologist, that referral is clinically appropriate and should be covered.

Cervical Cerclage Denials

Cervical cerclage is a surgical procedure where sutures are placed around the cervix to prevent preterm birth or second-trimester pregnancy loss in women with cervical incompetence. ACOG Practice Bulletin No. 142 supports cerclage for women with:

• A history of second-trimester pregnancy loss with painless cervical dilation
• Ultrasound-detected short cervix (less than 25mm before 24 weeks) with prior preterm birth

If your insurer denied cerclage as "elective" or "not medically necessary," this is a dangerous and incorrect denial. Cite ACOG Practice Bulletin No. 142 in your appeal. Have your MFM or OB provide documentation of your cervical length measurements and obstetric history.

17-OHPC Injections for Preterm Prevention

17-hydroxyprogesterone caproate (17-OHPC, brand name Makena) was FDA-approved for reducing preterm birth risk in women with a prior spontaneous preterm birth. Note: the FDA withdrew approval of Makena in 2023 based on a confirmatory trial, but 17-OHPC is still prescribed off-label and compounded versions remain available.

Insurers may deny 17-OHPC based on the withdrawal of the branded version's approval. However, when prescribed by an MFM specialist for a patient with a documented history of prior preterm birth and supporting clinical evidence, the denial of 17-OHPC can be appealed as medically appropriate off-label use. Many state Medicaid programs continue to cover compounded 17-OHPC.

Perinatologist/MFM Specialist Referral Denials

Insurers sometimes deny referrals to maternal-fetal medicine specialists by claiming the service is not medically necessary or that no Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization was obtained. For a diagnosed high-risk pregnancy condition, an MFM referral is the standard of care per ACOG guidelines. Your appeal should include:

• Your specific high-risk diagnosis
• Your OB's referral documentation
• A statement from your MFM specialist, if already seen, documenting why ongoing specialist care is necessary
• Relevant ACOG Practice Bulletins supporting specialist involvement

If the denial was due to lack of prior authorization, check whether your plan allows retroactive authorization for urgent specialist referrals.

Fetal Monitoring Denials

For high-risk pregnancies, increased fetal monitoring — including non-stress tests (NSTs), biophysical profiles (BPPs), and Doppler velocimetry — is standard care. Insurers sometimes restrict the frequency of these tests or require repeated prior authorizations.

If your provider has ordered weekly or twice-weekly NSTs for conditions like gestational hypertension, fetal growth restriction, or post-dates pregnancy, the clinical basis is well-established. ACOG antepartum fetal surveillance guidelines (Practice Bulletin No. 229) support these monitoring protocols. Document the clinical indication in your appeal.

NICU Pre-Authorization

When a high-risk delivery is anticipated, NICU admission may need to be pre-authorized. Insurers sometimes deny or delay NICU pre-authorization, or deny it retroactively after the fact.

Critically, NICU admission after an emergency delivery cannot be denied for lack of prior authorization under the ACA and EMTALA. Emergency medical conditions — which include a newborn requiring intensive care — must be stabilized regardless of authorization status.

If your insurer is denying NICU coverage retroactively, appeal citing:

• EMTALA (Emergency Medical Treatment and Labor Act)
• The ACA's prohibition on requiring prior authorization for emergency care
• Medical records documenting the emergency nature of the NICU admission

How to Appeal High-Risk Pregnancy Denials

Step 1: Obtain all denial letters. Request written denial for every denied service separately.

Step 2: Gather complete obstetric records. This includes prior pregnancy records, current cervical length measurements, genetic screening results, specialist notes, and hospital records.

Step 3: Have your MFM or OB write a detailed letter of medical necessity. This letter should cite specific ACOG Practice Bulletins and explain the clinical risk to mother and baby if coverage is denied.

Step 4: Request expedited appeal. For ongoing pregnancy care, you are entitled to a 72-hour expedited review. Emphasize the time-sensitive nature of pregnancy.

Step 5: Contact your state insurance commissioner. Denials of medically necessary high-risk pregnancy care are serious and reviewable by state regulators.

Fight Back With ClaimBack

High-risk pregnancy denials can have life-altering consequences. ClaimBack generates a clinically grounded, urgent appeal letter tailored to your specific high-risk condition and the care being denied.

Start your free appeal at ClaimBack

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs. External Insurance Appeal: What's the Difference?